Imunon, Inc. (IMNN) Financials
IMNN Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 15.0 million | 10.8 million |
| March 31, 2026 | 8.0 million | 4.7 million |
| Dec. 31, 2025 | 12.3 million | 5.2 million |
| Sept. 30, 2025 | 9.0 million | 4.9 million |
IMNN Free Cash Flow and Stock based compensation
No data available :(
IMNN Net Income
No data available :(
IMNN Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 6.9 million | 5.5 million | 811190 |
| March 31, 2026 | 4.8 million | - | 492849 |
| Dec. 31, 2025 | 8.8 million | - | 1.0 million |
| Sept. 30, 2025 | 5.3 million | - | 1.1 million |
IMNN Shares Outstanding
IMNN Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 69.1 million | 1.5 million | 1.3 million | - |
| March 31, 2026 | 4 | 2.3 million | 2.0 billion | - |
| Dec. 31, 2025 | 3589 | 2.5 million | 1.8 million | - |
| Sept. 30, 2025 | 3 | 1.9 million | 1.6 million | - |
IMNN Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | - | - |
| March 31, 2026 | - | 166544 |
| Dec. 31, 2025 | -725202 | 169265 |
| Sept. 30, 2025 | - | 167034 |
IMNN
Price: $1.64
52 week price:
Earnings Per Share: -2.92 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 9.0 million